Literature DB >> 20810657

A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5'-phosphatase (SHIP1).

Jun Zhang1, Kodi S Ravichandran, James C Garrison.   

Abstract

The Src homology 2 domain-containing inositol 5'-phosphatase 1 (SHIP1) dephosphorylates phosphatidylinositol 3,4,5-trisphosphate to phophatidylinositol 3,4-bisphosphate in hematopoietic cells to regulate multiple cell signaling pathways. SHIP1 can be phosphorylated by the cyclic AMP-dependent protein kinase (PKA), resulting in an increase in SHIP1 activity (Zhang, J., Walk, S. F., Ravichandran, K. S., and Garrison, J. C. (2009) J. Biol. Chem. 284, 20070-20078). Using a combination of approaches, we identified the serine residue regulating SHIP1 activity. After mass spectrometric identification of 17 serine and threonine residues on SHIP1 as being phosphorylated by PKA in vitro, studies with truncation mutants of SHIP1 narrowed the phosphorylation site to the catalytic region between residues 400 and 866. Of the two candidate phosphorylation sites located in this region (Ser(440) and Ser(774)), only mutation of Ser(440) to Ala abolished the ability of PKA to phosphorylate the purified, catalytic domain of SHIP1 (residues 401-866). Mutation of Ser(440) to Ala in full-length SHIP1 abrogated the ability of PKA to increase the activity of SHIP1 in mammalian cells. Using flow cytometry, we found that the PKA activator, Sp-adenosine 3',5'-cyclic monophosphorothioate triethylammonium salt hydrate (Sp-cAMPS) blunted the phosphorylation of Akt downstream of B cell antigen receptor engagement in SHIP1-null DT40 B lymphocytes expressing native mouse SHIP1. The inhibitory effect of Sp-cAMPS was absent in cells expressing the S440A mutant of SHIP1. These results suggest that activation of SHIP1 by PKA via phosphorylation on Ser(440) is an important regulatory event in hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810657      PMCID: PMC2966099          DOI: 10.1074/jbc.M110.128827

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  The role of PI3K in immune cells.

Authors:  Shigeo Koyasu
Journal:  Nat Immunol       Date:  2003-04       Impact factor: 25.606

Review 2.  PI3K in lymphocyte development, differentiation and activation.

Authors:  Klaus Okkenhaug; Bart Vanhaesebroeck
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

3.  Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.

Authors:  Arthur R Salomon; Scott B Ficarro; Laurence M Brill; Achim Brinker; Qui T Phung; Christer Ericson; Karsten Sauer; Ansgar Brock; David M Horn; Peter G Schultz; Eric C Peters
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-09       Impact factor: 11.205

Review 4.  The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.

Authors:  Katrien Backers; Daniel Blero; Nathalie Paternotte; Jing Zhang; Christophe Erneux
Journal:  Adv Enzyme Regul       Date:  2003

5.  Specific tyrosine phosphorylations mediate signal-dependent stimulation of SHIP2 inositol phosphatase activity, while the SH2 domain confers an inhibitory effect to maintain the basal activity.

Authors:  Nagendra K Prasad; Michael E Werner; Stuart J Decker
Journal:  Biochemistry       Date:  2009-07-14       Impact factor: 3.162

Review 6.  The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.

Authors:  Lisa M Ooms; Kristy A Horan; Parvin Rahman; Gillian Seaton; Rajendra Gurung; Dharini S Kethesparan; Christina A Mitchell
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

7.  Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.

Authors:  Jun Zhang; Scott F Walk; Kodi S Ravichandran; James C Garrison
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

Review 8.  The role of SHIP in macrophages.

Authors:  Laura M Sly; Victor Ho; Frann Antignano; Jens Ruschmann; Melisa Hamilton; Vivian Lam; Michael J Rauh; Gerald Krystal
Journal:  Front Biosci       Date:  2007-05-01

Review 9.  Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes.

Authors:  Stephanie J Harris; Richard V Parry; John Westwick; Stephen G Ward
Journal:  J Biol Chem       Date:  2007-12-10       Impact factor: 5.157

10.  The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2.

Authors:  Ian H Batty; Jeroen van der Kaay; Alex Gray; Joan F Telfer; Miles J Dixon; C Peter Downes
Journal:  Biochem J       Date:  2007-10-15       Impact factor: 3.857

View more
  6 in total

1.  Regulation of alveolar macrophage p40phox: hierarchy of activating kinases and their inhibition by PGE2.

Authors:  Emilie Bourdonnay; Carlos H Serezani; David M Aronoff; Marc Peters-Golden
Journal:  J Leukoc Biol       Date:  2012-04-27       Impact factor: 4.962

Review 2.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

3.  Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system: success, disappointment, and new opportunities.

Authors:  Matthew D Blunt; Stephen G Ward
Journal:  Front Immunol       Date:  2012-08-02       Impact factor: 7.561

Review 4.  Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.

Authors:  Selena Vigano; Dimitrios Alatzoglou; Melita Irving; Christine Ménétrier-Caux; Christophe Caux; Pedro Romero; George Coukos
Journal:  Front Immunol       Date:  2019-06-06       Impact factor: 7.561

Review 5.  Targeting SHIP1 and SHIP2 in Cancer.

Authors:  Chiara Pedicone; Shea T Meyer; John D Chisholm; William G Kerr
Journal:  Cancers (Basel)       Date:  2021-02-20       Impact factor: 6.639

6.  The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions.

Authors:  Samantha D Pauls; Sandrine T Lafarge; Ivan Landego; Tingting Zhang; Aaron J Marshall
Journal:  Front Immunol       Date:  2012-08-09       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.